[Preliminary observations on the use of L-DOPA in the treatment of the akinetic symptoms of Parkinson's disease].
D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D013566:Sympathomimetics / Q000627:therapeutic use*
D013566:Sympathomimetics; D004295:Dihydroxyphenylalanine
Prime osservazioni sull'uso di L-DOPA nel trattamento della sintomatologia acinetica del morbo di Parkinson.